2015
DOI: 10.1016/j.antiviral.2015.09.010
|View full text |Cite
|
Sign up to set email alerts
|

Modeling rotavirus infection and antiviral therapy using primary intestinal organoids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
170
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 158 publications
(178 citation statements)
references
References 33 publications
7
170
0
1
Order By: Relevance
“…This differs from reports in mice, in which exogenous treatment with IFN-λ is more protective against enteric viral replication than type I IFN (55,56), and type I IFN is primarily considered to inhibit systemic spread of enteric viruses (17,56,75). This difference may be a result of the type I IFN subtype tested; previous studies in mice and HIEs used an IFN-α subtype rather than IFN-β for exogenous treatment (17,55,56,83); however, IFN-α2 was significantly weaker than IFN-β in restricting HRV growth in HIEs. Heterogeneity in the host response to different type I IFNs has been previously characterized; IFN-β binds the type I IFN receptor with greater affinity than IFN-α2 (84), and other viral pathogens including LCMV and HCV have differing sensitivities to IFN-α and IFN-β (60).…”
Section: Discussionmentioning
confidence: 60%
“…This differs from reports in mice, in which exogenous treatment with IFN-λ is more protective against enteric viral replication than type I IFN (55,56), and type I IFN is primarily considered to inhibit systemic spread of enteric viruses (17,56,75). This difference may be a result of the type I IFN subtype tested; previous studies in mice and HIEs used an IFN-α subtype rather than IFN-β for exogenous treatment (17,55,56,83); however, IFN-α2 was significantly weaker than IFN-β in restricting HRV growth in HIEs. Heterogeneity in the host response to different type I IFNs has been previously characterized; IFN-β binds the type I IFN receptor with greater affinity than IFN-α2 (84), and other viral pathogens including LCMV and HCV have differing sensitivities to IFN-α and IFN-β (60).…”
Section: Discussionmentioning
confidence: 60%
“…Both human proximal small intestinal enteroids and HIOs have been shown to model human rotavirus infection 39,60,81,82 . Rotavirus replicates and produces infectious virions in enteroids and HIOs, with viral replication increasing over 96 h 60,82 .…”
Section: Host–pathogen Interactionsmentioning
confidence: 99%
“…Rotavirus replicates and produces infectious virions in enteroids and HIOs, with viral replication increasing over 96 h 60,82 . Moreover, an increased degree of infection (~50%) in differentiated human enteroids exposed to human rotavirus has been demonstrated compared to simian strains 60 .…”
Section: Host–pathogen Interactionsmentioning
confidence: 99%
“…Rotaviruses not only efficiently replicated in the organoids, but infected organoids also produced infectious virus particles. Viral replication could be blocked by treatment of the infected organoids with the antiviral agents interferon-α or ribavirin (Yin et al, 2015). Another striking example of organoid-virus co-culture is the use of induced pluripotent stem cell (iPSC)-derived brain organoids to investigate the effects of Zika virus (ZIKV) infection on brain development (Qian et al, 2017).…”
Section: Host-pathogen Interactionsmentioning
confidence: 99%